Actas Esp Psiquiatr 2017 Sep 1;45(5):201-17. Epub 2017 Sep 1.
Hospital Universitario 12 de Octubre. Madrid Instituto de Investigación i+12. Madrid Red de Trastornos adictivos (RETIS) Departamento de Psiquiatría. Facultad de Medicina. Universidad Complutense. Madrid.
Encephale 2006 Jan-Feb;32(1 Pt 1):45-59
Département de Psychiatrie, Hôpitaux Universitaires de Genève, 2, chemin du Petit-Bel-Air, CH-1225 Chêne-Bourg, Suisse.
Introduction: Although everyone working in routine mental health services recognizes the scientific and ethical importance to ensure that treatments being provided are of highest quality, there is a clear lack of consensus regarding what outcome domains to include, what measure of assessment to use and, moreover, who to question when assessing.
Literature Findings: Since the fifties, social functioning is considered as an important dimension to take into account for treatment planning and outcome measuring. But for many years, symptoms scales have been considered as sufficient outcome measures and social functioning improvement expected on the basis of symptoms alleviation. Read More
Ideggyogy Sz 2011 Mar;64(3-4):128-32
Semmelweis Egyetem, Pszichiátriai és Pszichoterápiás Klinika, Budapest.
Cognitive dysfunction is a core feature in schizophrenia and has a great impact on psychosocial functioning. Still it remains unclear, whether the different diagnostic subgroups have a specific cognitive profile. The topic of this research was to investigate the neurocognitive characteristics of deficit and non-deficit schizophrenia, and to examine if the two diagnostic subgroups have a qualitative difference in cognitive functioning. Read More
Encephale 2008 Dec 9;34(6):557-62. Epub 2008 Jul 9.
Service de psychiatrie, CHI de Clermont-de-l'Oise, Clermont-de-l'Oise, France.
Background: An increasing interest in the study of cognition in Schizophrenia has developed within the last few years although cognitive problems have been described in this disorder since the beginning of the 20th century. Presently, various data tend to assert that cognitive disorders are the core disturbance in schizophrenia and that their severity is predictive of the course of the disease. Indeed, studies have shown that the disturbances measured in cognitive tests are neither the consequences of positive or negative symptoms, nor related to motivation or global intellectual deficit, nor to anti-psychotic medication. Read More